Studies Open to Enrollment
studies Heading link
Purpose 2 / Lenacapavir Long-acting Investigational PrEP Trial
Hello, Chicagoland!
Project WISH in the Department of Medicine at the University of Illinois Chicago (UIC) is conducting a Phase 3 long-acting investigational PrEP trial. Would you like to volunteer for a 2x/year PrEP injectable trial?
You may qualify. Are you:
- Currently not on PrEP?
- 18 years of age or older?
- Wanting HIV testing, but haven’t done it in 3 months?
- Bottoming and only sometimes use a condom?
Studies Open to Enrollment Heading link
- Any part of any of the following groups:
- Race/Ethnicity
- American Indian
- Asian
- Black
- Latinx (of any race)
- Native Hawaiian or Pacific Islander
- White (if you are transgender/nonbinary or if you identify as Latinx)
- Mixed ancestry
- Gender Identity:
- Cisgender man (of color, Latinx, or of mixed ancestry) who has sex with men
- Transgender men/women or gender nonbinary individuals (of any race/ethnicity)
- Race/Ethnicity
For more information about the Gilead lenacapavir investigational trial and how to join, email us at ProjectWISHdom@uic.edu or call us at 312.413.5897. Additionally, you may go to the study website at https://www.purposestudies.com/purpose2/ and/or Clin Trials.gov at https://clinicaltrials.gov/ct2/show/NCT04925752to learn more about the study, look at reasons to consider participation, and check out the clinical research and study FAQ lists.
UIC Principal Investigator(s):
- Richard M. Novak, MD (he/him)
Study Coordinator:
- Diana Bahena (she/her)
Community Affairs Specialist:
- Charlie Peterson (he/him)